Searchable abstracts of presentations at key conferences in endocrinology

ea0081ep133 | Calcium and Bone | ECE2022

Metabolic parameters in patients with primary hyperparathyroidism before and after parathyroidectomy

Bibik Ekaterina , Dobreva Ekaterina , Miliutina Anastasia , Elfimova Alina , Eremkina Anna , Mokrysheva Natalia

Background: Metabolic syndrome may be the nonclassical feature of primary hyperparathyroidism (PHPT) because an increased incidence of various glucose and lipid disorders is often observed in patients with this disease. Earlier we showed PHPT patients had higher serum triglycerides and higher rate of insulin resistance compared to the control group. Dynamics of metabolic parameters after surgery is ambiguous.The aim: of this study was to compare metaboli...

ea0081ep137 | Calcium and Bone | ECE2022

Glomerular filtration rate 12 months after parathyroidectomy in patients with primary hyperparathyroidism

Elfimova Alina , Eremkina Anna , Rebrova Olga , Kovaleva Elena , Miliutina Anastasia , Mokrysheva Natalia

Background: In some patients with primary hyperparathyroidism (PHPT), glomerular filtration rate (GFR) demonstrate decrease after parathyroidectomy (PTE). GFR may decrease immediately after surgery due to general anesthesia, but after a month not all patients restore kidney function; a decreased GFR is also observed after 1–2 years after surgery.Aim: To find the pre-surgical factors of GFR decrease after PTE.Methods: Patients ...

ea0081ep332 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

The impact of the interventions based on mobile apps in physical activity among people with Type 2 diabetes mellitus

Lykoudi Elissavet , Vlachou Eugenia , Evangelou Eleni , Ntikoudi Anastasia , Dokoutsidou Eleni , Margari Nikoletta

Introduction: The mobile health (mHealth) technologies use mobiles and also wireless network and devices to offer services for improving health, promoting behavior changes and supporting self-management. The increasing global use of mobile application (app) is widely accepted in managing chronic diseases and especially among people with type 2 diabetes mellitus (T2DM).Aim: The purpose of this study was to identify the impact of the interventions based on...

ea0050oc6.4 | Bone, Calcium and Neoplasia | SFEBES2017

G-protein coupled oestrogen receptor mediates Hippo pathway signalling and survival outcomes in colorectal cancer patients

Basker Karthik , Arvaniti Anastasia , Rahman Habibur , Gondal Ali , Gilligan Lorna , Foster Paul

Oestrogenic effects on colorectal cancer (CRC) incidence, proliferation, and patient survival remains controversial. We have previously shown enzymic pathways favouring oestradiol (E2) synthesis are upregulated in CRC, and stimulation of the G-protein coupled oestrogen receptor (GPER) by E2 increases CRC proliferation. Here we interrogated The Cancer Genome Atlas (TCGA) Colon Adenocarcinoma (COAD) database to determine all oestrogen metabolism enzymes and...

ea0050p057 | Bone and Calcium | SFEBES2017

Imaging in primary hyperparathyroidism; does it affect our referral pathways for surgery? Results of an audit

Dede Anastasia , Morganstein Daniel , Shotliff Kevin , Greener Veronica , Smellie James , Maenhout Annelies , Wren Alison

Introduction: The 4th International Workshop on asymptomatic primary hyperparathyroidism (PHPT) has set criteria for surgical intervention and suggests that a percentage of patients can be managed conservatively. Imaging is indicated only pre-operatively to determine the optimal surgical approach.Patients and methods: We completed an audit on the use of Sestamibi, clinical and biochemical data in patients with PHPT.<...

ea0050oc6.4 | Bone, Calcium and Neoplasia | SFEBES2017

G-protein coupled oestrogen receptor mediates Hippo pathway signalling and survival outcomes in colorectal cancer patients

Basker Karthik , Arvaniti Anastasia , Rahman Habibur , Gondal Ali , Gilligan Lorna , Foster Paul

Oestrogenic effects on colorectal cancer (CRC) incidence, proliferation, and patient survival remains controversial. We have previously shown enzymic pathways favouring oestradiol (E2) synthesis are upregulated in CRC, and stimulation of the G-protein coupled oestrogen receptor (GPER) by E2 increases CRC proliferation. Here we interrogated The Cancer Genome Atlas (TCGA) Colon Adenocarcinoma (COAD) database to determine all oestrogen metabolism enzymes and...

ea0050p057 | Bone and Calcium | SFEBES2017

Imaging in primary hyperparathyroidism; does it affect our referral pathways for surgery? Results of an audit

Dede Anastasia , Morganstein Daniel , Shotliff Kevin , Greener Veronica , Smellie James , Maenhout Annelies , Wren Alison

Introduction: The 4th International Workshop on asymptomatic primary hyperparathyroidism (PHPT) has set criteria for surgical intervention and suggests that a percentage of patients can be managed conservatively. Imaging is indicated only pre-operatively to determine the optimal surgical approach.Patients and methods: We completed an audit on the use of Sestamibi, clinical and biochemical data in patients with PHPT.<...

ea0084ps3-13-120 | Pregnancy & Iodine | ETA2022

The impact of thyroid function on neonatal outcome in women with polycystic ovary syndrome treated with metformin or placebo during pregnancy

Trouva Anastasia , Alvarsson Michael , Calissendorff Jan , Olav AEsvold Bjorn , Linden Hirschberg Angelica , Vanky Eszter

Objectives: Polycystic ovary syndrome (PCOS) and thyroid disorders have separately been linked to adverse pregnancy and neonatal outcomes. Even small variations in thyroid function within the normal range may influence fetal growth. Previous data have shown that metformin-treatment of pregnant women with PCOS reduced late miscarriages and preterm births, and resulted in less decrease of fT4 compared to placebo. Moreover, metformin exposure in utero altered the offspring anthro...

ea0086oc5.2 | Metabolism, Obesity and Diabetes | SFEBES2022

7α-hydroxy-3-oxo-4-cholestenoic acid (7-HOCA) is a novel AKR1D1 substrate driving metabolic dysfunction and hepatocellular cancer risk in patients with non-alcoholic fatty liver disease (NAFLD)

Nikolaou Nikolaos , Arvaniti Anastasia , Sanna Fabio , da Conceicao Ismael , Dempster Niall , Gathercole Laura , Tomlinson Jeremy

Non-alcoholic fatty liver disease (NAFLD) is a spectrum of disease ranging from intrahepatic lipid accumulation to fibrosis, cirrhosis, and hepatocellular carcinoma (HCC). Liver 5β-reductase (AKR1D1) catalyses a fundamental step in bile acid (BA) synthesis. BAs and BA intermediates are potent regulators of metabolic and proliferative phenotype. We have hypothesised that AKR1D1 plays a crucial role in NAFLD and HCC. Liver biopsies and serum samples were obtained from healt...

ea0090ep226 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Impact of Hybrid Closed-Loop Systems on Diabetes Management Compared to Sensor-Assisted Pump Systems

Ntikoudi Anastasia , Vlachou Eugenia , Evangelou Eleni , Tsartsalis Athanasios , Komninos John , Mastorakos George

Background and Aim: Over the past years, hybrid closed-loop (HCL) systems have emerged as the state-of-the art treatment of type 1 diabetes (T1D), and there is sufficient evidence to support their safety and value. The aim of this review was to evaluate all the available literature regarding the impact of HCL systems on diabetes management compared to sensor augmented pump (SAP) systems.Methods: An extensive literature search was conducted through electr...